XPH - SPDR® S&P® Pharmaceuticals ETF (USD) (US78464A7220)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US78464A7220

XPH ISIN

Exchange Traded Funds (ETF)

Fondstyp

SPDR State Street Global Advisors

Anbieter

70,47 USD

NAV pro Aktie | 07/08/2026

16/06/2006

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOILS

CFI

XPH

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

USA

Geographie

S&P Pharmaceuticals Select Industry Index

Benchmark

0.35 %

Gesamtkostenquote

513,03 Mio. USD

Gesamtes Fondsvermögen | 06/08/2026

Nein

UCITS

Rendite auf 07/08/2026, NYSE Arca

YTD

1,13 %
1M

-5,91 %
3M

-2,73 %
6M

7,29 %
1J

38,48 %
3J

42,34 %
5J

18,07 %
10J

47,64 %

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (XPH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible the price and yield performance of the S&P Pharmaceuticals Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the pharmaceutical industry

XPH profile

The SPDR® S&P® Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 16.06.2006 with unique ISIN - US78464A7220. Main exchange is NYSE Arca and ticker symbol is XPH. The total expense ratio is 0.35%. The SPDR® S&P® Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Struktur XPH auf 06/08/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
CRINETICS PHARMACEUTICALS IN	3,58%
MBX BIOSCIENCES INC	3,17%
DEFINIUM THERAPEUTICS INC	2,91%
ATAIBECKLEY INC	2,78%
AMYLYX PHARMACEUTICALS INC	2,63%
ENLIVEN THERAPEUTICS INC	2,39%
ALUMIS INC	2,03%
CORCEPT THERAPEUTICS INC	2,02%
TREVI THERAPEUTICS INC	2,02%
LIQUIDIA CORP	2,01%
EDGEWISE THERAPEUTICS INC	1,98%
NUVATION BIO INC	1,95%
NEKTAR THERAPEUTICS	1,89%
OMEROS CORP	1,89%
LIGAND PHARMACEUTICALS	1,77%
AMNEAL PHARMACEUTICALS INC	1,73%
VERADERMICS INC	1,71%
MAZE THERAPEUTICS INC	1,7%
BRISTOL MYERS SQUIBB CO	1,69%
PERRIGO CO PLC	1,64%
JAZZ PHARMACEUTICALS PLC	1,64%
HARROW INC	1,63%
PRESTIGE CONSUMER HEALTHCARE	1,62%
PACIRA BIOSCIENCES INC	1,6%
HARMONY BIOSCIENCES HOLDINGS	1,6%
ETON PHARMACEUTICALS INC	1,6%
MERCK + CO. INC.	1,58%
JOHNSON + JOHNSON	1,58%
TARSUS PHARMACEUTICALS INC	1,56%
WAVE LIFE SCIENCES LTD	1,56%
ELANCO ANIMAL HEALTH INC	1,55%
ROYALTY PHARMA PLC CL A	1,54%
ELI LILLY + CO	1,54%
RAPPORT THERAPEUTICS INC	1,54%
EYEPOINT INC	1,52%
SUPERNUS PHARMACEUTICALS INC	1,52%
VIATRIS INC	1,51%
PFIZER INC	1,5%
INDIVIOR PHARMACEUTICALS INC	1,49%
ORGANON + CO	1,48%
ANI PHARMACEUTICALS INC	1,48%
OCULAR THERAPEUTIX INC	1,46%
PHIBRO ANIMAL HEALTH CORP A	1,39%
ZOETIS INC	1,39%
INNOVIVA INC	1,34%
ARVINAS INC	1,25%
AXSOME THERAPEUTICS INC	1,25%
XERIS BIOPHARMA HOLDINGS INC	1,24%
COLLEGIUM PHARMACEUTICAL INC	1,23%
ALTO NEUROSCIENCE INC	1,21%
AMPHASTAR PHARMACEUTICALS IN	1,18%
LB PHARMACEUTICALS INC	1,14%
SEPTERNA INC	1,12%
ACLARIS THERAPEUTICS INC	0,99%
ZEVRA THERAPEUTICS INC	0,98%
CORMEDIX INC	0,93%
THERAVANCE BIOPHARMA INC	0,91%
PHATHOM PHARMACEUTICALS INC	0,79%
RELMADA THERAPEUTICS INC	0,79%
AQUESTIVE THERAPEUTICS INC	0,69%
FULCRUM THERAPEUTICS INC	0,68%
BIOAGE LABS INC	0,66%
LEXICON PHARMACEUTICALS INC	0,59%
EVOLUS INC	0,54%
SSI US GOV MONEY MARKET CLASS	0,08%
CONTRA ESPERION THERAP	0,01%
US DOLLAR	0%

Alle anzeigen Verstecken

Andere - %